Below we share two important, recent updates related to COVID-19 vaccines.
Bivalent Pfizer-BioNTech COVID-19 Vaccine as Booster Dose for Certain Children Ages 6 Months through 4 Years
On Thursday, March 16, CDC recommended the Pfizer-BioNTech COVID-19 bivalent vaccine as a booster for children ages 6 months-4 years. See the CDC recommendation.
These recommendations follows FDA’s March 14 amendment of the emergency use authorization (EUA) of the Pfizer-BioNTech COVID-19 bivalent vaccine.
Moderna Monovalent COVID-19 Vaccine Expiration
The Moderna monovalent COVID-19 vaccine for ages 6+ expires in early April. Consult CDC’s web content on interchangeability of COVID-19 vaccine products for guidance on completing primary series vaccination for patients who have received an initial dose or doses of the Moderna monovalent vaccine.
CDC also offers guidance on disposing of expired vaccine product on its Identifying, Disposing, and Reporting COVID-19 Vaccine Wastage website.
COVID-19 Response Program Office Hours
If you have questions, bring them to our next Office Hours! Even if your health center does not order vaccines (or any COVID-19 supplies) through HRSA, you’re welcome to attend.
Tuesday, March 28 1:00-2:00 p.m. ET Registration page
NOTE: We’ve extended this webinar series. Even if you previously registered for past office hours, you need to register again for this new set of sessions.
Though some information may be geared toward COVID-19 Response Program participants, these office hours are open to all HRSA-supported health centers. We encourage all health centers to register.
You may also submit questions via the BPHC Contact Form.
|